Skip to main content
Close
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > News > From Survivor to Healer: Jeanne T. Paz Fights for a Cure

From Survivor to Healer: Jeanne T. Paz Fights for a Cure

News | February 22, 2019
Tags
autism brain disorders dementia epilepsy neurology neuroscience optogenetics
Share this page
Twitter Facebook LinkedIn

Creative Promise Prizewinner Jeanne T. Paz first heard her calling to heal as a child in her native Georgia. Then part of the Soviet Union, the country was riven by sectional violence and economic instability.

After being caught in the crossfire of a street gunfight, her cousin was hospitalized; it was unknown whether he would survive, and Jeanne visited him every day for months. “I remember walking on the streets and not knowing if I was going to come back alive,” she says. At the hospital, she observed surgeries conducted by candlelight and the frantic pace at which doctors and nurses tended to their charges. It was never enough, and Jeanne resolved then to become a doctor herself: “That experience was really transformative for me.”

Jeanne was so motivated that she began medical school at the age of 17. By then, she had moved to France with her mother, who was working as a particle physicist at the CERN research organization. Two years into her education, however, she realized that her ability to treat patients was prescribed by the limits of medical knowledge, and thus she decided to pursue research instead.

She entered the master’s program for neuroscience at the Collège de France and began studying epilepsy there with neuroscientist Stéphane Charpier. As a master’s—and, later, doctoral—candidate in Stéphane’s lab, Jeanne used rodent models to study the brain mechanisms underlying epileptic seizures, and eventually discovered the connection between seizures and a group of brain cells called the basal ganglia. Jeanne then showed that by using drugs to inhibit another group of neurons known as the substantia nigra, which help fine-tune the activity of basal ganglia neurons, seizures could be controlled and stopped.

This discovery was an important advance in the search for epilepsy treatments, and eager to do more, Jeanne moved to the U.S. for a postdoctoral fellowship with Karl Deisseroth at Stanford University. Karl was then pioneering a research technique known as optogenetics, in which brain cells in living animals are genetically engineered to respond to light, allowing scientists to visualize the neural circuitry in the brain and how it corresponds to various functions and disorders.

Optogenetics presented an appealing avenue of inquiry for Jeanne; although there were many descriptive studies of epileptic brains and the ways in which they differed from those of people without epilepsy, it was unknown exactly what these differences meant. Some changes were adaptive—beneficial changes that helped the brain function despite seizures—while others were maladaptive, a generative cause of seizures.

“Without knowing what changes were bad, treatment could actually have devastating effects,” Jeanne says. “With optogenetic tools, I realized this was an inflection point in the field because the tools allowed us, for the first time, to target and control specific cell types or areas in the brain and ask whether activating or inhibiting that cell type in real time was sufficient to shut down a seizure.”

And indeed, through optogenetics, Jeanne was able to show that in a brain with stroke damage, dampening the activity of neurons in the thalamus could immediately disrupt a seizure. Her lab was the first to demonstrate this link, and her work has led to clinical trials of using electronic forms of thalamic stimulation to stop seizures.

Based on her research at Stanford, Jeanne received the prestigious Pathway to Independence Award from the National Institutes of Health. The prize included a $1 million grant, which allows an investigator to start their own lab, and in 2014, Jeanne set up shop at the Gladstone Institutes. She has since held dual positions as an assistant investigator at the Gladstone Institute for Neurological Disease and assistant professor at the University of California, San Francisco.

The position allows Jeanne to mentor students at UCSF while conducting research at an institution that prizes innovative approaches to human disease. “It was the perfect place for me to go,” Jeanne says. “I get to have both worlds.”

The appointment also enables Jeanne to conduct basic research while still being active on the medical side. Currently, her lab is investigating the nuances between epilepsy generated from different causes; some, for example, are caused by stroke and traumatic brain injury, while others are genetic, such as Dravet syndrome. “For each of the different epilepsies, we are finding slightly different spots in the brain that we call choke points, points that can be targeted to stop or prevent seizures,” she says.

Jeanne then collaborates with clinicians at UCSF to ensure that her lab’s findings translate into something useful for treating patients. Recently, her lab has been analyzing electroencephalography scans from the patients of her colleagues, and initial findings have suggested that certain signature brain waves could be used to predict a seizure before it starts.

“We could use those to tell a patient, ‘You’re going to have a seizure in five minutes, so stop driving, or stay at home,’” Jeanne says. “Because a major problem for patients is the unpredictability of seizures.”

It has been a long journey from the days of watching her cousin fight for his life in an understaffed hospital. While the Vilcek Prize for Creative Promise will surely not be the last prize Jeanne receives, it is the most personal: “It’s not easy to succeed as an immigrant,” she says. “Coming as a no one, from a difficult country, and then being given the opportunity to fight for success—it was about survival, and that’s what this prize recognizes.”

Read Jeanne’s full biography >

Tags
autism brain disorders dementia epilepsy neurology neuroscience optogenetics
Share this page
Twitter Facebook LinkedIn

Related News

August 6, 2020

New research offers minimally invasive approach to deep brain stimulation

Creative Promise Prizewinner Viviana Gradinaru receives the Science & PINS Prize for Neuromodulation, for her innovative Parkinson’s Research
Viviana Gradinaru and lab members conduct an experiment in her lab.
March 30, 2020

Viviana Gradinaru: “Make Yourself Useful.”

Viviana Gradinaru credits her upbringing in Communist Romania with fostering ingenuity in problem-solving, and a passion for exploring hard science.
Viviana Gradinaru is the Professor of Neuroscience and Biological Engineering at Caltech.
October 18, 2022

Vilcek Foundation honors immigrant scientists with $250,000 in prizes

Alejandro Sánchez Alvarado, Edward Chouchani, Biyu J. He, and Shixin Liu receive the 2023 Vilcek Foundation Prizes in Biomedical Science.
The 2023 Vilcek Prizewinners in biomedical science from left to right: Edward Chouchani, Alejandro Sánchez Alvarado, Biyu J. He, & Shixin Liu.

You may also be interested in

Jeanne T. Paz

Jeanne T. Paz receives the Vilcek Prize for Creative Promise in Biomedical Science for uncovering the neural basis of epileptic seizures, and for demonstrating possible methods of predicting and arresting seizures.
Portrait of Jeanne Paz

Viviana Gradinaru

Viviana Gradinaru receives the Vilcek Prize for Creative Promise in Biomedical Science for developing next-generation tools in optogenetics, tissue clearing, and gene delivery, with potential therapeutic applications in human diseases.
Portrait of Viviana Gradinaru

Biyu J. He

Biyu J. He receives the Vilcek Prize for Creative Promise in Biomedical Science for her leadership in the field of cognitive neuroscience, and for her groundbreaking discoveries on the biological bases of perceptual cognition and subjective experience.
Portrait of Biyu J. He.

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2023   Vilcek Foundation